glp 1 postmenopausal women GLP-1s and Hormone Therapy: A Game-Changing Duo for Menopause Belly Fat Semaglutide Review: 'The Drug Helped

In liver disease, non-invasive approaches such as transient elastography, magnetic resonance elastography (MRE), and serum fibrosis panels (e.g., ELF score, Pro-C3) can be readily applied in incretin-based trials

Symptoms suggesting hypoglycaemia require urgent attention, particularly in patients taking GLP-1 receptor agonists alongside insulin or sulphonylureas

Its also important to screen for any history of eating disorders, as the appetite-suppressing effects of GLP-1s may pose risks for certain individuals

In other words, the mechanism makes microdosing biologically plausible, but reliable outcomes remain tied to dose levels that have been studied

Further evidence is needed to accurately assess other applications of the drug class